LSD1/2-IN-4 是一种 PCPA 衍生物，是 LSD1 和 LSD2 的抑制剂。LSD1/2-IN-4 对 LSD1 和 LSD2 具有抑制作用，其Ki值分别为 0.11 μM 和 130 μM。LSD1/2-IN-4 可用于多种癌症的研究，如 T 细胞急性淋巴细胞白血病 (TALL) 。

LSD1/2-IN-4 is a PCPA derivative which is an inhibitor of lysine-specific demethylase 1 (LSD1) and lysine-specific demethylase 2 (LSD2). LSD1/2-IN-4 inhibits LSD1 and LSD2 with K i values of 0.11 μM and 130 μM, respectively. LSD1/2-IN-4 can be used for the research of several cancers including T-cell acute lymphoblastic leukemia (TALL) [1].

LSD1/2-IN-4 has strong inhibitory activity against both LSD1 and LSD2 with K i values of 0.11 μM and 130 μM, respectively and not inhibits peroxidase with an IC 50 >500 μM [1].

C9H8BrF2N

248.07

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years